fulvestrant has been researched along with ru 58668 in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (44.44) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bouchoux, F; Brémaud, J; Hameau, MC; Lucas, D; Moratille, C; Nique, F; Philibert, D; Teutsch, G; Van de Velde, P; Viet, S | 1 |
| Brémaud, J; Hameau, MC; Magnien, V; Nique, F; Philibert, D; Planchon, P; Prévost, G; Teutsch, G; Van de Velde, P | 1 |
| Jensen, EV; Knabbe, C; Müller, V | 1 |
| McGinnis, MY; Vagell, ME | 1 |
| Chakraborty, P; Droogmans, G; Maertens, C; Nilius, B | 1 |
| Atkin, SL; Bilko, D; Newton, CJ; Pappa, S | 1 |
| Gougelet, A; Maillard, S; Marsaud, V; Renoir, JM | 1 |
| Espelund, U; Jepsen, JS; Juncker-Jensen, A; Lykkesfeldt, AE; Ralfkiaer, U; Worm, J | 1 |
| McDonnell, DP; Sherk, A; Wittmann, BM | 1 |
9 other study(ies) available for fulvestrant and ru 58668
| Article | Year |
|---|---|
RU 58,668, a new pure antiestrogen inducing a regression of human mammary carcinoma implanted in nude mice.
Topics: Animals; Antineoplastic Agents; Cell Division; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Neoplasm Transplantation; Progesterone; Rabbits; Rats; Receptors, Estrogen; Tamoxifen; Thymus Gland; Tumor Cells, Cultured; Uterus | 1994 |
RU 58668: further in vitro and in vivo pharmacological data related to its antitumoral activity.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carcinogenicity Tests; Cell Cycle; Cell Division; Chick Embryo; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Genes, ras; Heart; Humans; Kinetics; Mice; Mice, Inbred BALB C; Mice, Nude; Myocardium; Neoplasm Invasiveness; Tamoxifen; Tumor Cells, Cultured | 1996 |
Partial antagonism between steroidal and nonsteroidal antiestrogens in human breast cancer cell lines.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Division; Drug Interactions; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Transforming Growth Factor beta; Tumor Cells, Cultured | 1998 |
The role of gonadal steroid receptor activation in the restoration of sociosexual behavior in adult male rats.
Topics: Amygdala; Androgen Receptor Antagonists; Animals; Brain Chemistry; Copulation; Estradiol; Estrogen Antagonists; Estrus; Female; Fulvestrant; Male; Orchiectomy; Organ Size; Pheromones; Pituitary Gland; Preoptic Area; Rats; Rats, Inbred Strains; Receptors, Androgen; Receptors, Estrogen; Scent Glands; Seminal Vesicles; Septal Nuclei; Social Behavior; Testosterone; Vocalization, Animal | 1998 |
Inhibition of volume-regulated anion channels in cultured endothelial cells by the anti-oestrogens clomiphene and nafoxidine.
Topics: Cell Division; Cells, Cultured; Chloride Channels; Clomiphene; Enclomiphene; Endothelium, Vascular; Estradiol; Estrogen Antagonists; Fulvestrant; Humans; Membrane Potentials; Nafoxidine; Patch-Clamp Techniques; Pulmonary Artery | 2001 |
Dexamethasone blocks antioestrogen- and oxidant-induced death of pituitary tumour cells.
Topics: Adenosine Triphosphate; Cell Death; Dexamethasone; Estradiol; Estrogen Receptor Modulators; Estrone; Flow Cytometry; Flutamide; Fulvestrant; Glucocorticoids; Glyceraldehyde-3-Phosphate Dehydrogenases; Gonanes; Humans; Hydrogen Peroxide; Microscopy, Fluorescence; Mifepristone; Pituitary Neoplasms; Reactive Oxygen Species; Receptor Cross-Talk; Receptors, Cell Surface; Transfection; Tumor Cells, Cultured | 2001 |
Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Line, Tumor; Cyclic AMP-Dependent Protein Kinases; Cysteine Endopeptidases; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor Modulators; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Kinetics; Ligands; MAP Kinase Kinase Kinases; Multienzyme Complexes; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Proteasome Endopeptidase Complex; Protein Kinase C; Protein Kinase Inhibitors; Protein Kinases; Receptors, Estrogen; Tamoxifen; Transcription, Genetic | 2003 |
Insulin-like growth factor binding protein 2 is a marker for antiestrogen resistant human breast cancer cell lines but is not a major growth regulator.
Topics: Biomarkers, Tumor; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Drug Resistance, Neoplasm; Estradiol; Estrogen Antagonists; Estrogens; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Insulin-Like Growth Factor Binding Protein 2; Insulin-Like Growth Factor Binding Proteins; Oligonucleotide Array Sequence Analysis; Oligonucleotides, Antisense; Polyunsaturated Alkamides; Receptor, IGF Type 1; Tamoxifen | 2006 |
Definition of functionally important mechanistic differences among selective estrogen receptor down-regulators.
Topics: Amino Acid Sequence; Binding Sites; Breast Neoplasms; Cell Line, Tumor; Cinnamates; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor Modulators; Fulvestrant; HeLa Cells; Humans; Molecular Sequence Data; Protein Conformation; Stilbenes; Subcellular Fractions | 2007 |